Marja Hensen is Director Strategic Market Access in our Rotterdam office in the Netherlands. She is leading the European Strategic Market Access Center of Excellence at Pharmerit. Marja has expertise in strategic market access and pricing and reimbursement research, systematic literature reviews, HEOR evidence generation plans, HTA / reimbursement dossiers, (global) value dossiers, payer surveys, landscape analyses, cost-effectiveness and budget impact modelling, PRO studies, and dissemination of findings. Disease areas she has worked in include vaccines, haemophilia, infectious diseases, oncology, transplantation, auto-immune diseases, mental disorders, diabetes, urology, respiratory diseases, disease-related malnutrition, pain, orphan diseases, ophthalmology and others.
Marja has extensive experience in guiding large projects from phase II through submission. She has presented work at conferences including ISPOR, EFIC, ESH and EHA. Marja authored articles in Expert Review of Hematology, Diabetes Research and Clinical Practice, Haematologica and Applied Health Economics and Health Policy. She holds a MSc degree in Biomedical Sciences from the University of Leiden. She joined Pharmerit in 2006 and since then performed and led a large number of projects.